ICR | Biotech fears ‘dangerous’ precedent as judge challenges FDA authority

Biotech fears ‘dangerous’ precedent as judge challenges FDA authority

A federal judge’s decision to revoke the approval of an abortion pill rippled across the biotechnology industry over the weekend, as industry leaders warned the ruling could threaten the Food and Drug Administration’s authority to regulate medicines.

The oldest independent membership-led professional body for clinical researchers across the globe.